Center Laboratories, Inc (4123)

Overview

Center Laboratories, Inc. is a notable figure in the global pharmaceutical industry, established in 1959 and based in Taipei City, Taiwan. With a focus on both local and international markets, the company has carved out a niche for itself in the pharmaceutical manufacturing and trading arena. It drives innovation through its extensive research and development efforts, particularly in the creation of small molecule drugs aimed at addressing neurological and oncological diseases. Embracing a diverse portfolio, Center Laboratories, Inc. not only specializes in pharmaceuticals but also extends its expertise to the development of medical devices, software as a medical device, and nutritional health solutions among other sectors. This wide-ranging involvement is underpinned by its engagement in pharmaceutical CDMO, agribiotechnology, as well as cutting-edge fields like stem cell and immune cell therapy, demonstrating the company’s commitment to advancing healthcare and medicine through innovation and strategic industry investments and venture capital endeavors.

Products and Services

• Small Molecule Drugs

  Focused on neurological and oncological diseases, Center Laboratories, Inc. engages in rigorous research and development to bring forth small molecule medications designed to treat these challenging conditions effectively.

• Proteins and Antibodies Development

  The company dedicates significant resources to the development of proteins and antibodies. This pivotal area of research supports the creation of innovative therapeutic solutions, contributing to the advancement of medical treatments in various diseases.

• Pharmaceutical CDMO

  Center Laboratories, Inc. provides comprehensive Contract Development and Manufacturing Organization (CDMO) services, offering an integrated suite of solutions from drug development through to manufacturing, assisting partners in bringing their pharmaceutical products to market more efficiently.

• Medical Device and Software as Medical Device

  The company's portfolio extends to the development and innovation of medical devices, including software solutions classified as medical devices. These efforts reflect its commitment to enhancing patient care through technology.

• Nutritional Health

  Center Laboratories, Inc. also ventures into the nutritional health sector, developing products that complement its medical offerings by promoting wellness and preventive care through nutritional support.

• Agribiotechnology

  This area focuses on the application of biotechnology in agriculture, aiming to improve crop yields, pest resistance, and nutritional value, demonstrating the company's versatility and commitment to leveraging science for broader societal benefits.

• Stem Cell and Immune Cell Therapy

  In the forefront of medical innovation, the company invests in the research and development of therapies utilizing stem and immune cells, aiming to offer groundbreaking treatments for a variety of diseases.

• Industry Investment and Venture Capital

  Center Laboratories, Inc. actively engages in industry investments and venture capital, supporting startups and innovative technologies in healthcare and biotechnology that align with its vision of advancing medical science and patient care.

• Glass Fibre Pressure Vessels

  As part of its diverse product offerings, the company manufactures glass fibre pressure vessels, showcasing its capability to produce high-quality industrial products alongside its pharmaceutical and biotechnological innovations.